The store will not work correctly when cookies are disabled.
5-nitro-N-(quinolin-2-yl)nicotinamide
ID: ALA4095322
PubChem CID: 137652656
Max Phase: Preclinical
Molecular Formula: C15H10N4O3
Molecular Weight: 294.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc2ccccc2n1)c1cncc([N+](=O)[O-])c1
Standard InChI: InChI=1S/C15H10N4O3/c20-15(11-7-12(19(21)22)9-16-8-11)18-14-6-5-10-3-1-2-4-13(10)17-14/h1-9H,(H,17,18,20)
Standard InChI Key: NOCQSSKMZXDVJI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
4.2166 -8.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2155 -9.1028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9235 -9.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6332 -9.1024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6303 -8.2797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9217 -7.8744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3415 -9.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3428 -10.3270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0486 -9.1002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7569 -9.5076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7536 -10.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4611 -10.7307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4571 -9.0958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1652 -9.4995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1681 -10.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8794 -10.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5881 -10.3129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5812 -9.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8695 -9.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5074 -9.5109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8000 -9.1017 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5068 -10.3281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 15 2 0
14 13 2 0
13 10 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 20 1 0
20 21 2 0
20 22 1 0
M CHG 2 20 1 22 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.27 | Molecular Weight (Monoisotopic): 294.0753 | AlogP: 2.79 | #Rotatable Bonds: 3 |
Polar Surface Area: 98.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.65 | CX Basic pKa: 2.09 | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.59 | Np Likeness Score: -1.78 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |